scispace - formally typeset
C

Cecilia Magnusson

Researcher at Karolinska Institutet

Publications -  189
Citations -  13407

Cecilia Magnusson is an academic researcher from Karolinska Institutet. The author has contributed to research in topics: Population & Odds ratio. The author has an hindex of 56, co-authored 177 publications receiving 11539 citations. Previous affiliations of Cecilia Magnusson include Lund University & Stockholm County Council.

Papers
More filters
Journal ArticleDOI

Alcohol, tobacco and breast cancer - Collaborative reanalysis of individual data from 53 epidemiological studies, including 58 515 women with breast cancer and 95 067 women without the disease

Nobuyuki Hamajima, +219 more
TL;DR: In conclusion, smoking has little or no independent effect on the risk of developing breast cancer; the effect of alcohol on breast cancer needs to be interpreted in the context of its beneficial effects, in moderation, on cardiovascular disease and its harmful effects on cirrhosis.
Journal ArticleDOI

Menarche, menopause, and breast cancer risk: Individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies

Nobuyuki Hamajima, +292 more
- 01 Nov 2012 - 
TL;DR: The effects of menarche and menopause on breast cancer risk might not be acting merely by lengthening women's total number of reproductive years, and endogenous ovarian hormones are more relevant for oestrogen receptor-positive disease than for ostrogens receptor-negative disease and for lobular than for ductal tumours.
Journal ArticleDOI

Risk of Endometrial Cancer Following Estrogen Replacement With and Without Progestins

TL;DR: The risk of developing endometrial cancer is increased after long-term use of estrogens without progestins and with cyclically added progestin use, and Continuously added progESTins may be needed to minimize the endometricrial cancer risk associated with estrogen replacement therapy.
Journal ArticleDOI

Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy.

TL;DR: A positive association which was noted for use of oestrogen combined with testosterone‐derived progestins appeared especially pronounced with continuously combined regimens, which may substantially increase the incidence of post‐menopausal breast cancer, particularly among non‐obese women.
Journal ArticleDOI

Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence

Nobuyuki Hamajima, +294 more
- 29 Aug 2019 - 
TL;DR: Every MHT type, except vaginal oestrogens, was associated with excess breast cancer risks, which increased steadily with duration of use and were greater for oestrogen-progestagen than oest estrogen-only preparations; among current users, these excess risks were definite even during years 1–4.